Implementing Pathways to Improve Pediatric Asthma Care
- Conditions
- Asthma
- Interventions
- Behavioral: PIPA Intervention Bundle 1Behavioral: PIPA Intervention Bundle 2
- Registration Number
- NCT03736603
- Lead Sponsor
- University of California, San Francisco
- Brief Summary
Background:
Asthma affects nearly 10% of American children, and is a leading cause of pediatric emergency visits and hospitalizations. Clinical pathways are operational versions of practice guidelines aimed at the hospital management of common illnesses. Single-site studies of pediatric asthma pathways have shown significant improvements in quality of care.
Primary Objective:
To evaluate the effectiveness of clinical pathways for improving quality of care for children with asthma in a diverse, national sample of emergency department (ED) and hospital settings.
Primary Endpoints:
1. Emergency Department: The proportion of eligible children who receive systemic steroids within 60 minutes of ED arrival
2. Inpatient/Hospital: Mean length of hospital stay
Study Design:
This project will be implemented through an established quality improvement collaborative of hospitals across the United States, the Value in Inpatient Pediatrics Network (part of the American Academy of Pediatrics). A cluster randomized design will be employed. Group 1 hospitals will receive a multifaceted implementation strategy that includes: 1) a pathway implementation toolkit, 2) local multidisciplinary champions in the ED and inpatient settings, 3) audit and feedback, 4) educational seminars, and 5) practice facilitation (via teleconference). Group 2 will receive the same intervention with the addition of a mobile app pathway tool.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 303
- Working as a physician at the study site
- None
Patient/child eligibility criteria:
Inclusion Criteria:
- Age 2-17 years
- Primary diagnosis of asthma
Exclusion Criteria:
- Transferred in from another inpatient facility
- Presence of a chronic medical condition that precludes pathway use
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Pathway Intervention 1 PIPA Intervention Bundle 1 Hospitals randomized to group 1 receive PIPA Intervention Bundle 1. Pathway Intervention 2 PIPA Intervention Bundle 2 Hospitals randomized to group 2 receive PIPA Intervention Bundle 2, which adds a mobile app.
- Primary Outcome Measures
Name Time Method Hospital/Inpatient: Mean length of hospital stay 1 year Emergency Department: Proportion of eligible children who receive systemic steroids within 60 minutes of ED arrival 1 year
- Secondary Outcome Measures
Name Time Method Hospital/Inpatient: Proportion of children screened for secondhand tobacco smoke exposure 1 year Hospital/Inpatient: Proportion of children prescribed antibiotics at hospital discharge 1 year Hospital/Inpatient: Proportion of children with administration of bronchodilator via metered-dose inhaler early in hospitalization 1 year Hospital/Inpatient: Proportion of children with emergency department visits or readmissions to the hospital within 7 days 1 year Emergency Department: Proportion of children who get an asthma exacerbation severity assessment at ED triage 1 year Emergency Department: Proportion of children who have chest radiographs performed 1 year Hospital/Inpatient: Proportion of children who screen positive for secondhand tobacco smoke exposure whose caregivers are referred to smoking cessation resources 1 year Hospital/Inpatient: Proportion of children transferred to a higher level of care 1 year Emergency Department: Proportion of children transferred to a higher level of care 1 year Emergency Department: Proportion of children admitted to the hospital 1 year Emergency Department: Mean length of emergency department stay 1 year
Trial Locations
- Locations (1)
University of California
🇺🇸San Francisco, California, United States